KEGG   DRUG: D05263Help
Entry
D05263                      Drug                                   

Name
Onercept (USAN/INN)
Formula
C753H1156N228O247S25
Exact mass
18143.7923
Mol weight
18156.2401
Sequence
DSVCPQGKYI HPQNNSICCT KCHKGTYLYN DCPGPGQDTD CRECESGSFT ASENHLRHCL
SCSKCRKEMG QVEISSCTVD RDTVCGCRKN QYRHYWSENL FQCFCCSLCL NGTVHLSCQE
KQNTVCTCHA GFFLRENECV SCSNCKKSLE CTKLCLPQIE N
(Disulfide bridge: 4-18; 19-32; 22-41; 44-59; 62-77; 65-85; 87-103; 106-118; 109-126; 128-139; 142-151; 145-155)
  Type
Peptide
Activity
Anti-TNF (tumor necrosis factor) activity
Comment
fusion protein
a recombinant human soluble type I TNF receptor (p55) [HSA:7132] [KO:K03158]
Target
TNF-alpha [HSA:7124] [KO:K03156]
  Pathway
hsa04010  MAPK signaling pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04064  NF-kappa B signaling pathway
hsa04350  TGF-beta signaling pathway  
 
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines
  TNF family
   TNF-alpha
    Onercept
     D05263  Onercept (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
199685-57-9
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system